Molecular Partners AG Stock: price and insider trades · Switzerland
No insider purchase over the last 90 days. The latest, by Anonymous (Executive member of the board of directors / member of senior management), was filed 01 Nov 2023.
Molecular Partners AG: what insiders have been doing
Molecular Partners AG, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SIX SER. Over the twelve months to 27 October 2026, 2 filings were filed, from 1 insider.
The flow runs one way only: 2 sales worth €184k, from 1 insider, and no purchase. At €150k, the sale published on 27 November 2025 is the largest of the period.
Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Compared with its exchange (178 companies, median 10 filings), a count of 2 filings is below the norm. Over the whole record (from 2023), the tally stands at 1 purchase and 5 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Source: insider filings from SIX SER. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- Anonymous (Executive member of the board of directors / member of senior management)+54.0%Entry CHF 3.50 · Close at T+365 CHF 5.39
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- ▼Anonymous (Executive member of the board of directors / member of senior management)30,841 CHF12SIX9,563 shares@ CHF 3.2256.3% of flowISIN CH0256379097SIX:T1Q4200077
- ▼Anonymous (Executive member of the board of directors / member of senior management)140,000 CHF14SIX35,000 shares@ CHF 4.0028.3% of flowISIN CH0256379097SIX:T1PBR00010
- ▼Anonymous (Executive member of the board of directors / member of senior management)47,785 CHF12SIX45,080 shares@ CHF 1.069.6% of flowISIN CH0256379097SIX:T1O99000F0
- ▼Anonymous (Executive member of the board of directors / member of senior management)13,822 CHF11SIX13,040 shares@ CHF 1.062.8% of flowISIN CH0256379097SIX:T1O99000E3
- ▼Anonymous (Executive member of the board of directors / member of senior management)243,000 CHF16SIX60,000 shares@ CHF 4.0546.8% of flowISIN CH0256379097SIX:T1O4200049
- ▲Anonymous (Executive member of the board of directors / member of senior management)31,761 CHF12SIX10,000 shares@ CHF 3.17610.026% mcap6.2% of flowISIN CH0256379097SIX:T1NB100071Canonical exit: 30 Jan 2024 (T+90)
6 of 6 declarations
About Molecular Partners AG
Molecular Partners AG is a Swiss biopharmaceutical company focused on developing protein-based therapies. It is listed on the Swiss stock exchange XSWX.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
